ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 34 filers reported holding ENTRADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $887,154 | +4.4% | 56,149 | 0.0% | 0.00% | – |
Q2 2023 | $850,096 | +22.9% | 56,149 | +17.7% | 0.00% | – |
Q1 2023 | $691,824 | +19.0% | 47,712 | +15.8% | 0.00% | – |
Q4 2022 | $581,504 | -9.1% | 41,206 | +0.1% | 0.00% | – |
Q3 2022 | $639,972 | +20.2% | 41,175 | 0.0% | 0.00% | – |
Q2 2022 | $532,417 | +35.4% | 41,175 | 0.0% | 0.00% | – |
Q1 2022 | $393,140 | – | 41,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,425,784 | $69,750,000 | 26.57% |
5AM Venture Management, LLC | 4,408,379 | $69,476,000 | 13.31% |
72 Investment Holdings, LLC | 509,023 | $8,022,000 | 6.36% |
TCG Crossover Management, LLC | 642,189 | $10,121,000 | 3.04% |
StepStone Group LP | 761,277 | $11,998,000 | 1.71% |
Nan Fung Group Holdings Ltd | 141,593 | $2,232,000 | 1.42% |
Redmile Group, LLC | 1,954,419 | $30,802,000 | 1.20% |
Baker Brothers Advisors | 4,865,819 | $76,685,000 | 0.50% |
MOORE CAPITAL MANAGEMENT, LP | 105,000 | $1,655,000 | 0.04% |
Laurion Capital Management LP | 199,066 | $3,137,000 | 0.02% |